September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
ALPHA-1 ANTITRYPSIN DIMINISHED ANGIOGENESIS IN HUMAN MICROVASCULAR CELLS EXPOSED TO HYPERGLYCEMIA.
Author Affiliations & Notes
  • Juan E Gallo
    Ophthalmology, Hospital Universitario Austral, Pilar, Buenos Aires, Argentina
    Nanomedicine & Vision Group - Facultad de Ciencias Biomedicas, Universidad Austral, Pilar , Argentina
  • Gustavo Ortiz
    Nanomedicine & Vision Group - Facultad de Ciencias Biomedicas, Universidad Austral, Pilar , Argentina
  • Juan Pablo Salica
    Ophthalmology, Hospital Universitario Austral, Pilar, Buenos Aires, Argentina
    Nanomedicine & Vision Group - Facultad de Ciencias Biomedicas, Universidad Austral, Pilar , Argentina
  • Eduardo Chuluyan
    Pharmacology, Universidad de Buenos Aires, Buenos Aires, Argentina
  • Footnotes
    Commercial Relationships   Juan Gallo, None; Gustavo Ortiz, None; Juan Salica, None; Eduardo Chuluyan, None
  • Footnotes
    Support  Austral University Research Grant
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 4523. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Juan E Gallo, Gustavo Ortiz, Juan Pablo Salica, Eduardo Chuluyan; ALPHA-1 ANTITRYPSIN DIMINISHED ANGIOGENESIS IN HUMAN MICROVASCULAR CELLS EXPOSED TO HYPERGLYCEMIA.. Invest. Ophthalmol. Vis. Sci. 2016;57(12):4523.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We have previously shown that AAT diminished the activity of MMP-2 and lowered the levels of IL-6 in human microvascular endothelial cells exposed to hyperglycemia. In the present study we aim to analyze the effect of AAT on VEGF and angiogenesis.

Methods : The HMEC-1 cell line were maintained in DMEM Medium supplemented with 50 and 100 mM glucose, 10% foetal bovine serum and 0.48% (w/v) HEPES, pH 7.4, in a CO2 humid incubation chamber at 37°C. The cells were exposed to 0, 1.5, and 3 mg/ml of AAT (Prolastin C®) and incubated for 3, 5 and 7 days. VEGF was measured with ELISA and angiogenesis was evaluated through the formation of capillary tubes measuring the amount of branching points.

Results : VEGF increased over time for both 50mM and 100 mM glucose in control and in those treated with AAT. However, we observed that the number of branching points (BP) decreased with the use of AAT both at 5 and 7 days of culture. In particular when we used 1.5 mg/ml of AAT at 5 days the branching point diminished a third part, reaching a half part at 7 days when compared to the control condition. Furthermore, the BP diminish over time at both concentration of AAT, 1.5 and 3 mg/ml.

Conclusions : AAT seems to modulate the mechanism of initial angiogenesis. Its antiangiogenic effect might be useful for the treatment of early diabetic retinopathy.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×